Compare CRI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRI | ABCL |
|---|---|---|
| Founded | 1865 | 2012 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2003 | 2020 |
| Metric | CRI | ABCL |
|---|---|---|
| Price | $36.84 | $3.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $32.60 | $7.75 |
| AVG Volume (30 Days) | 1.3M | ★ 5.3M |
| Earning Date | 02-24-2026 | 02-24-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.45 | N/A |
| Revenue | ★ $2,832,687,000.00 | $35,325,000.00 |
| Revenue This Year | $2.49 | $25.45 |
| Revenue Next Year | $0.10 | $10.07 |
| P/E Ratio | $15.00 | ★ N/A |
| Revenue Growth | N/A | ★ 7.17 |
| 52 Week Low | $23.38 | $1.89 |
| 52 Week High | $54.58 | $6.52 |
| Indicator | CRI | ABCL |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 31.04 |
| Support Level | $32.24 | $2.75 |
| Resistance Level | $38.88 | $3.69 |
| Average True Range (ATR) | 1.67 | 0.28 |
| MACD | 0.20 | -0.15 |
| Stochastic Oscillator | 85.89 | 8.55 |
Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.